Monday, April 27, 2015 Last update: 3:33 AM - Covering Large & Obscure Tech Companies Since 1996

NanoViricides, Inc.

News articles for NanoViricides, Inc.:

Monday, April 20, 2015

Monday, April 6, 2015

  • NanoViricides Provides an Update on Its Progress over the Last Quarter
    SHELTON, Conn., April 6, 2015 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), a nanomedicine company developing anti-viral drugs, reports on the Company's progress in the recent quarter. EbolaUsing NanoViricides's rapid design platform, it took only 4 months from design to synthesis of the multiple EbolaCide drug ... read more

Monday, March 9, 2015

Wednesday, February 25, 2015

  • NanoViricides Files Quarterly Report for Period Ending 2014-12-31
    WEST HAVEN, Conn., Feb. 25, 2015 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), filed its quarterly report with the Securities and Exchange Commission on Tuesday, February 24th. The submission can be downloaded from the SEC website at The Company estimates that it now has ... read more

Friday, January 23, 2015

Thursday, January 22, 2015

Wednesday, January 21, 2015

Wednesday, January 7, 2015

  • NanoViricides, Inc. Completes Purchase of cGMP-compliant Pilot Production Facility
    WEST HAVEN, Conn., Jan. 7, 2015 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), has completed the purchase of the state of the art cGMP-compliant Manufacturing and R&D facility located in Shelton, Connecticut, from Inno-Haven, LLC. The Company purchased the facility solely by repaying for the ... read more

Wednesday, November 19, 2014

Monday, November 17, 2014